Cancer

September 20, 2018

Chic Awearness event supports VUMC ovarian cancer research

The T.J. Martell Foundation’s 6th Annual Chic Awearness fundraising event that supports ovarian cancer research at Vanderbilt-Ingram Cancer Center will be held Monday, Sept. 24, 6:30 – 8:30 p.m.

By Tom Wilemon
August 16, 2018

A new target for lung cancer

Vanderbilt researchers have identified a new vulnerability in lung cancer — the transporter protein xCT — that may a therapeutic target for the disease.

By Leigh MacMillan
August 2, 2018

Connecting an asthma gene to leukemia

A receptor previously implicated in asthma may also play roles in other allergic diseases and in leukemia, Vanderbilt researchers have discovered.

By Leigh MacMillan
July 2, 2018

SMAD4 clue to colon cancer

Loss of a gene that is part of the TGF-beta signaling pathway increased inflammation in the colon and was observed in half of human colitis-associated cancers.

By Bill Snyder
June 28, 2018

Team identifies new gene candidates for breast cancer risk

Jun. 28, 2018—An international coalition led by scientists at Vanderbilt University Medical Center and the QIMR Berghofer Medical Research Institute in Herston, Australia, has identified 48 candidate susceptibility genes for breast cancer risk, including 14 genes at loci (chromosome regions) not yet reported for breast cancer.

By Bill Snyder
June 14, 2018

Lung cancer patients and advocates visit VUMC research labs

A group of young lung cancer patients and their family members recently toured research laboratories at Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center (VICC) to learn how investigators are working to find better therapies and possibly a cure for the disease.

By VUMC News and Communications
May 29, 2018

New research finds lung cancer risk drops substantially within five years of quitting smoking

Just because you stopped smoking years ago doesn’t mean you’re out of the woods when it comes to developing lung cancer.  That’s the “bad” news. The good news is your risk of lung cancer drops substantially within five years of quitting.
By Bill Snyder
May 24, 2018

New method to thwart false positives in CT-lung cancer screening

A team of investigators led by Fabien Maldonado, MD, associate professor of Medicine at Vanderbilt, and Tobias Peikert, MD, assistant professor of Medicine at Mayo Clinic, Rochester, Minnesota, has identified a new technology to address false positives in CT-based lung cancer screening. The study was published in the latest issue of PLOS One.
By VUMC News and Communications
May 10, 2018

Grant bolsters kidney cancer immunotherapy research

W. Kimryn Rathmell, MD, PhD, Cornelius Abernathy Craig Professor of Medicine and director of the Division of Hematology and Oncology at Vanderbilt-Ingram Cancer Center (VICC), has received a grant to research the role of immunosuppression in the tumor microenvironment for kidney cancer.
By Doug Campbell
May 4, 2018

New breast cancer targets

A special genetic analysis has revealed candidate genes associated with increased risk of breast cancer.
By Bill Snyder
May 3, 2018

New breast health clinic in Cool Springs makes debut

Patients at high risk for developing breast cancer can now be seen by a team of breast health experts in Cool Springs. The VU Breast Health Cool Springs clinic, located at 324 Cool Springs Blvd., Suite B, Franklin, provides a range of medical services for high-risk individuals.
By VUMC News and Communications
April 23, 2018

Toxin floats on lipid rafts

The bacterium H. pylori is a leading cause of stomach cancer, and Vanderbilt researchers are studying how one of its toxins gets into cells.
By Leigh MacMillan
April 19, 2018

Ingram sees recent cancer diagnosis as second chance

“When it’s you, it’s a whole different feeling,” Orrin Ingram said, gazing at logs burning in the fireplace.
By Tom Wilemon
1 … 34 35 36 37 38 … 69